← Back to Search

NAD+ Boosting Product

Limitless for High Blood Pressure

Phase 2
Waitlist Available
Led By David Crowley, MD
Research Sponsored by Limitless Research Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30
Awards & highlights

Summary

This trial is testing a supplement called 'Limitless' combined with a low-carb diet in adults aged 45-65 with hypertension who are not on statin therapy. The supplement aims to improve blood flow and reduce inflammation, while the diet helps stabilize blood sugar levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes to blood nitrate from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet
Peroxynitrite
Changes to blood pressure from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet
+3 more
Secondary study objectives
Changes to C-reactive protein from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet
Changes to C-reactive protein from pre- to 2.5-hours after acute dose supplementation with Limitless at baseline and at Day 30
Changes to L-arginine from pre- to 2.5-hours after acute dose supplementation with Limitless at baseline and at Day 30
+35 more
Other study objectives
Change in Alanine Aminotransferase After 30 day supplementation with Limitless in addition to a low carbohydrate diet
Change in Amount of Basophils After 30 day supplementation with Limitless in addition to a low carbohydrate diet
Change in Amount of Eosinophils After 30 day supplementation with Limitless in addition to a low carbohydrate diet
+26 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: LimitlessExperimental Treatment1 Intervention
Participants will be instructed to take Limitless capsules for 30 days starting with the first dose to be administered in clinic on Visit 2 (Day 1, Baseline). The last dose will occur in clinic on Visit 3 (Day 30). Participants will be instructed to take two capsules two hours with water after breakfast, and two capsules two hours after dinner. Do not take food after evening dose before bed. (i.e. no snacking or desserts.). If a dose is missed participants are instructed to skip that dose. Participants will be advised not to exceed four capsules daily.

Find a Location

Who is running the clinical trial?

KGK Science Inc.Industry Sponsor
78 Previous Clinical Trials
6,138 Total Patients Enrolled
Limitless Research Inc.Lead Sponsor
David Crowley, MDPrincipal InvestigatorKGK Science Inc.
35 Previous Clinical Trials
2,731 Total Patients Enrolled
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top